AEGON ASSET MANAGEMENT UK Plc trimmed its position in MetLife, Inc. (NYSE:MET – Free Report) by 3.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 433,747 shares of the financial services provider’s stock after selling 15,116 shares during the period. AEGON ASSET MANAGEMENT UK Plc’s holdings in MetLife were worth $35,771,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in the company. Carmichael Hill & Associates Inc. lifted its holdings in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC lifted its stake in MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 277 shares in the last quarter. Fortitude Family Office LLC boosted its holdings in MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 266 shares during the last quarter. Bank & Trust Co bought a new stake in shares of MetLife in the 2nd quarter worth $39,000. Finally, Crewe Advisors LLC raised its holdings in shares of MetLife by 602.5% in the second quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 482 shares during the last quarter. 89.81% of the stock is owned by institutional investors and hedge funds.
MetLife Stock Performance
NYSE MET opened at $81.03 on Friday. The company’s 50 day simple moving average is $81.03 and its two-hundred day simple moving average is $75.19. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 1 year low of $59.24 and a 1 year high of $86.94. The stock has a market capitalization of $56.11 billion, a PE ratio of 16.34, a P/E/G ratio of 0.76 and a beta of 1.05.
MetLife Announces Dividend
Analyst Ratings Changes
MET has been the subject of several recent analyst reports. Jefferies Financial Group upped their target price on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a report on Friday, September 27th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Friday, October 4th. Morgan Stanley cut their price target on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Monday, August 19th. TD Cowen assumed coverage on shares of MetLife in a report on Wednesday, October 9th. They set a “buy” rating and a $97.00 price objective for the company. Finally, Wells Fargo & Company increased their target price on shares of MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research report on Tuesday. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, MetLife has an average rating of “Moderate Buy” and an average price target of $88.46.
Read Our Latest Report on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- Investing in Travel Stocks Benefits
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- How to Calculate Options Profits
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.